Logo image of ATHX

ATHERSYS INC (ATHX) Stock Fundamental Analysis

NASDAQ:ATHX - Nasdaq - US04744L2051 - Common Stock - Currency: USD

0.1018  +0 (+3.77%)

After market: 0.0602 -0.04 (-40.86%)

Fundamental Rating

1

ATHX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 571 industry peers in the Biotechnology industry. ATHX has a bad profitability rating. Also its financial health evaluation is rather negative. ATHX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATHX had negative earnings in the past year.
ATHX had a negative operating cash flow in the past year.
ATHX had negative earnings in each of the past 5 years.
ATHX had a negative operating cash flow in each of the past 5 years.
ATHX Yearly Net Income VS EBIT VS OCF VS FCFATHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of ATHX (-452.29%) is worse than 97.84% of its industry peers.
Industry RankSector Rank
ROA -452.29%
ROE N/A
ROIC N/A
ROA(3y)-179.33%
ROA(5y)-136.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATHX Yearly ROA, ROE, ROICATHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 200 -200 400 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATHX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATHX Yearly Profit, Operating, Gross MarginsATHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 -1K -2K -3K -4K -5K

More info and screens

0

2. Health

2.1 Basic Checks

ATHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATHX has more shares outstanding than it did 1 year ago.
ATHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATHX Yearly Shares OutstandingATHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M
ATHX Yearly Total Debt VS Total AssetsATHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

ATHX has an Altman-Z score of -107.39. This is a bad value and indicates that ATHX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -107.39, ATHX is not doing good in the industry: 99.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -107.39
ROIC/WACCN/A
WACC9.64%
ATHX Yearly LT Debt VS Equity VS FCFATHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M -40M -60M

2.3 Liquidity

ATHX has a Current Ratio of 0.09. This is a bad value and indicates that ATHX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ATHX (0.09) is worse than 99.50% of its industry peers.
ATHX has a Quick Ratio of 0.09. This is a bad value and indicates that ATHX is not financially healthy enough and could expect problems in meeting its short term obligations.
ATHX has a worse Quick ratio (0.09) than 99.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
ATHX Yearly Current Assets VS Current LiabilitesATHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.35% over the past year.
ATHX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.60%.
The Revenue has been growing slightly by 7.52% on average over the past years.
EPS 1Y (TTM)64.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.44%
Revenue 1Y (TTM)-98.6%
Revenue growth 3Y-1.81%
Revenue growth 5Y7.52%
Sales Q2Q%-97.84%

3.2 Future

The Earnings Per Share is expected to grow by 23.63% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -25.99% on average over the next years. This is quite bad
EPS Next Y83.47%
EPS Next 2Y37.18%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ATHX Yearly Revenue VS EstimatesATHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ATHX Yearly EPS VS EstimatesATHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ATHX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATHX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATHX Price Earnings VS Forward Price EarningsATHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATHX Per share dataATHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

ATHX's earnings are expected to grow with 23.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.18%
EPS Next 3Y23.63%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATHX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATHERSYS INC

NASDAQ:ATHX (10/17/2023, 10:22:18 PM)

After market: 0.0602 -0.04 (-40.86%)

0.1018

+0 (+3.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-16 2023-08-16/amc
Earnings (Next)11-13 2023-11-13/amc
Inst Owners0%
Inst Owner Change-19.29%
Ins Owners90.58%
Ins Owner Change0%
Market Cap2.29M
Analysts82.86
Price Target5.61 (5410.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.83%
Min EPS beat(2)-109.6%
Max EPS beat(2)21.93%
EPS beat(4)3
Avg EPS beat(4)-10.23%
Min EPS beat(4)-109.6%
Max EPS beat(4)42.48%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.03
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS0.01
BVpS-1.66
TBVpS-1.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -452.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-179.33%
ROA(5y)-136.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 220%
Cap/Sales 953.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z -107.39
F-Score2
WACC9.64%
ROIC/WACCN/A
Cap/Depr(3y)84.54%
Cap/Depr(5y)102.88%
Cap/Sales(3y)37.58%
Cap/Sales(5y)25.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.44%
EPS Next Y83.47%
EPS Next 2Y37.18%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-98.6%
Revenue growth 3Y-1.81%
Revenue growth 5Y7.52%
Sales Q2Q%-97.84%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
EBIT growth 1Y49.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.64%
OCF growth 3YN/A
OCF growth 5YN/A